CoChat

Single-Cell Transcriptomic Profiling of Cholangiocyte Organoids Derived from Bile Ducts of Primary Sclerosing Cholangitis Patients

Open access

The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.

Abstract

BACKGROUND AND AIMS: Primary sclerosing cholangitis (PSC) is a chronic inflammatory liver disorder without effective medical treatment which is characterized by inflammation and fibrotic structures around the bile ducts. Biliary epithelial cells (cholangiocytes) are the target and potential disease drivers in PSC, yet little is known if cholangiocytes from PSC patients differ from non-PSC controls. To characterize cholangiocytes at early rather than end-stage disease, cholangiocyte organoids (COs) were derived from diseased bile ducts of PSC patients and compared to organoids generated from disease controls. METHODS: Cholangiocytes were obtained during endoscopic retrograde cholangiopancreatography (ERCP) brushing of diseased bile duct areas and expanded as organoids using previously established culture methods. Stable CO lines were analyzed for cell type identity, basic cholangiocyte function, and transcriptomic signature. RESULTS: We demonstrate that cholangiocytes, derived from the damaged area within the bile ducts of PSC patients, can be expanded in culture without displaying functional or genetic disease-related features. We further show that COs from patients who later were diagnosed with dysplasia exhibit higher expression of the cancer-associated genes PGC, FXYD2, MIR4435-2HG, and HES1. CONCLUSIONS: Our results demonstrate that PSC organoids are largely similar to control organoids after culture and highlight the significance of COs as a tool for regenerative medicine approaches as well as their potential for discovering new potential biomarkers for diagnosing cholangiocarcinoma.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10620-024-08570-y

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Characterization of cholangiocyte organoids generated from ERCP brushings. a Overview of cholangiocyte organoid (CO) derivation from ERCP brushing. b Representative brightfield images showing COs from a control patient and a patient affected by PSC. Scale bars 100 μm. c Representative flow cytometry histograms demonstrating expression of the key biliary marker EPCAM in control and PSC COs. d Expression of biliary markers in control and PSC COs by immunofluorescence. Scale bars 100 μm. e Representative images of COs from control and PSC patients demonstrating alkaline phosphatase (ALP) activity. Scale bars 100 μm. f COs from control and PSC patients demonstrate gamma-glutamyl transferase (GGT) activity at comparable levels. N = 4; ns, non-significant. g Expression of the biliary markers KRT19, KRT7, SOX9, GGT1, and CFTR by control and PSC COs, detected by quantitative-PCR. Housekeeping gene, HMBS; n = 4; ns, non-significant. h Rhodamine 123 assay demonstrating intact MDR1 transporter function in PSC COs. n = 40 organoids. Error bars represent s.d. i Correct localization of main cytoskeleton and tight junction markers in PSC COs, demonstrated by immunofluorescence. Scale bar 50 μm. CK7 cytokeratin 7, KRT19 keratin 19, SOX9 SRY-related high mobility group box transcription factor 9, GGT gamma-glutamyltransferase 1, CFTR cystic fibrosis transmembrane conductance regulator, ZO-1 zonula occludens-1 protein, MDR1 multidrug resistance protein 1, **** P < 0.0001
Fig. 1 Characterization of cholangiocyte organoids generated from ERCP brushings. a Overview of cholangiocyte organoid (CO) derivation from ERCP brushing. b Representative brightfield images showing COs from a control patient and a patient affected by PSC. Scale bars 100 μm. c Representative flow cytometry histograms demonstrating expression of the key biliary marker EPCAM in control and PSC COs. d Expression of biliary markers in control and PSC COs by immunofluorescence. Scale bars 100 μm. e Representative images of COs from control and PSC patients demonstrating alkaline phosphatase (ALP) activity. Scale bars 100 μm. f COs from control and PSC patients demonstrate gamma-glutamyl transferase (GGT) activity at comparable levels. N = 4; ns, non-significant. g Expression of the biliary markers KRT19, KRT7, SOX9, GGT1, and CFTR by control and PSC COs, detected by quantitative-PCR. Housekeeping gene, HMBS; n = 4; ns, non-significant. h Rhodamine 123 assay demonstrating intact MDR1 transporter function in PSC COs. n = 40 organoids. Error bars represent s.d. i Correct localization of main cytoskeleton and tight junction markers in PSC COs, demonstrated by immunofluorescence. Scale bar 50 μm. CK7 cytokeratin 7, KRT19 keratin 19, SOX9 SRY-related high mobility group box transcription factor 9, GGT gamma-glutamyltransferase 1, CFTR cystic fibrosis transmembrane conductance regulator, ZO-1 zonula occludens-1 protein, MDR1 multidrug resistance protein 1, **** P < 0.0001CC BY-NC · PubMed Central
Fig. 2 Cholangiocyte organoids from individual patients overlap in their transcriptomic profile. a UMAP plots illustrate a general transcriptomic overlap between individual COs from PSC (n = 10) and non-PSC patients (n = 3) after stable culture. b Identification of 12 separate clusters across all CO lines. c Proportion of cells from each patient contributing to each cholangiocyte cluster. d Number of cells per patient in each cell cluster. e Top 5 upregulated genes per cluster. UMAP Uniform Manifold Approximation and Projection, CO cholangiocyte organoid
Fig. 2 Cholangiocyte organoids from individual patients overlap in their transcriptomic profile. a UMAP plots illustrate a general transcriptomic overlap between individual COs from PSC (n = 10) and non-PSC patients (n = 3) after stable culture. b Identification of 12 separate clusters across all CO lines. c Proportion of cells from each patient contributing to each cholangiocyte cluster. d Number of cells per patient in each cell cluster. e Top 5 upregulated genes per cluster. UMAP Uniform Manifold Approximation and Projection, CO cholangiocyte organoidCC BY-NC · PubMed Central
Fig. 3 Transcriptional profiling reveals a strong overlap between cholangiocyte organoids from PSC patients and organoids from non-PSC patients. a UMAP plots show a general transcriptomic overlap between individual samples from (1) non-PSC (n = 3) and (2) PSC patients (n = 10) after organoid culture. b Heatmap demonstrating the top 10 up- and downregulated genes in PSC compared to the non-PSC group. c Most differential expressed genes between the PSC and non-PSC patient groups per cluster (log2FC > 0.5). UMAP Uniform Manifold Approximation and Projection, CO cholangiocyte organoid
Fig. 3 Transcriptional profiling reveals a strong overlap between cholangiocyte organoids from PSC patients and organoids from non-PSC patients. a UMAP plots show a general transcriptomic overlap between individual samples from (1) non-PSC (n = 3) and (2) PSC patients (n = 10) after organoid culture. b Heatmap demonstrating the top 10 up- and downregulated genes in PSC compared to the non-PSC group. c Most differential expressed genes between the PSC and non-PSC patient groups per cluster (log2FC > 0.5). UMAP Uniform Manifold Approximation and Projection, CO cholangiocyte organoidCC BY-NC · PubMed Central
Fig. 4 Transcriptomic similarities and clustering between the individual CO lines. Heatmap shows the complete transcriptomes of all CO samples. Differentially expressed genes are color coded according to the log scale. CO lines from patients who were later diagnosed with biliary malignancy are marked in bold. CO cholangiocyte organoid
Fig. 4 Transcriptomic similarities and clustering between the individual CO lines. Heatmap shows the complete transcriptomes of all CO samples. Differentially expressed genes are color coded according to the log scale. CO lines from patients who were later diagnosed with biliary malignancy are marked in bold. CO cholangiocyte organoidCC BY-NC · PubMed Central
Fig. 5 Transcriptional profiling reveals higher expression of the potential pan-cancer regulator PGC in cholangiocyte organoids derived from a CCA patient. a Top 20 differentiated genes in a CO sample generated from a patient who later was diagnosed with CCA (PSC CO line 5). b Top 20 differentiated genes in a PSC patient group diagnosed with CCA or biliary intraepithelial neoplasia stage I/II (BIL-IN) (n = 3) (diagnosis after cell isolation) compared to PSC patients without biliary malignancy (n = 7). CO cholangiocyte organoid
Fig. 5 Transcriptional profiling reveals higher expression of the potential pan-cancer regulator PGC in cholangiocyte organoids derived from a CCA patient. a Top 20 differentiated genes in a CO sample generated from a patient who later was diagnosed with CCA (PSC CO line 5). b Top 20 differentiated genes in a PSC patient group diagnosed with CCA or biliary intraepithelial neoplasia stage I/II (BIL-IN) (n = 3) (diagnosis after cell isolation) compared to PSC patients without biliary malignancy (n = 7). CO cholangiocyte organoidCC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Research works printed but not linked: 1

  1. Arash S, Munteanu A, Mohorianu I. ClustAssess: tools for assessing the robustness of single-cell clustering. bioRxiv. 2022; 2022–01.

Cited by

See all 17

Metadata

Authors
Frank, A. K., Chung, B. K., De Novales, M. L. L., Engesæter, L. K., Hoyle, H. W., Øgaard, J., Heslop, J., Karlsen, T. H., Tysoe, O., Brevini, T., Tchorz, J. S., Vallier, L., Mohorianu, I., Sampaziotis, F., & Melum, E.
Affiliations
  • Oslo University Hospital (NO)
  • Wellcome/MRC Cambridge Stem Cell Institute (GB)
  • Novartis (Switzerland) (CH)
  • Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
Corresponding author
Melum, Espen
Venue
Digestive Diseases and Sciences
Published
2024-08-19
Volume
69
Issue
10
Pages
3810-3823
ISSN
  • 0163-2116 (ISSN-L)
  • 1573-2568
OpenAlex
W4401691134
Cited by
14
References
41
Citations by year
2026: 7 · 2025: 6 · 2024: 1
FWCI
3.62
Type
journal article
Language
en
Open access
Licence
Locations
  • Digestive Diseases and Sciences (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • PUBLISSO (German National Library of Medicine) (submittedVersion, cc-by-nc)
  • Apollo (University of Cambridge) (submittedVersion, cc-by-nc)
Funders
  • Scientia Fellowship European Union`s Horizon 2020 research and innovation program (No 801133)
  • Norwegian PSC Research Center
  • European Research Council (New-Chol)
  • Norwegian Research council (315399)
  • University of Oslo
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords
primary sclerosing cholangitis, cholangiocytes, cholangiocyte organoids, bile ducts, single-cell transcriptomics, dysplasia, Hes1, PGC, FXYD2, MIR4435-2HG, regenerative medicine, endoscopic retrograde cholangiopancreatography
MeSH terms
Bile Ducts, Epithelial Cells, Female, Humans, Male, Organoids, Cholangitis, Sclerosing, Gene Expression Profiling, Single-Cell Analysis, Transcriptome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Single-Cell Transcriptomic Profiling of Cholangiocyte Organoids Derived from Bile Ducts of Primary Sclerosing Cholangitis Patients. https://app.cochat.ai/papers/10.1007/s10620-024-08570-y
The paper
Frank, A. K., Chung, B. K., De Novales, M. L. L., Engesæter, L. K., Hoyle, H. W., Øgaard, J., Heslop, J., Karlsen, T. H., Tysoe, O., Brevini, T., Tchorz, J. S., Vallier, L., Mohorianu, I., Sampaziotis, F., & Melum, E. (2024). Single-Cell Transcriptomic Profiling of Cholangiocyte Organoids Derived from Bile Ducts of Primary Sclerosing Cholangitis Patients. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-024-08570-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.